Subscribe To

Price Alert Latest News Economic Calendar News

NGENF / NervGen Pharma to Present at Upcoming Investor Conferences

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced today that members of its management will be presenting at two upcoming investor conferences: Mike Kelly, President & CEO, will present at the Life Science Investors Forum, hosted by OTC Markets Group on VirtualInvestorConferences.com, on June 22, 2023 at 11:30am Eastern Daylight Time (EDT), and members of management will be available for one-on-one investor meetings on June 26, 2023. LINK: https://OTCMarketsGroup_VIC This will be a live, interactive online event where investors are invited to ask the company questions in real-time. Read More

Demo Live Account See Partner Details

Content Topics

Nervgen

Pharma

Present

Upcoming

Investor

Conferences

Stock

NGENF

Posted: Jun 20 2023, 16:36

Author Name: Newsfile Corp

NGENF News

By Newsfile Corp
September 11, 2023

NervGen Pharma to Present at 2023 International Spinal Research Trust Network Meeting

Vancouver, British Columbia--(Newsfile Corp. - September 11, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a

By Newsfile Corp
June 20, 2023

NervGen Pharma to Present at Upcoming Investor Conferences

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clini

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.